In early 2017, the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) published the second of two focused updates to the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Both amendments to the original 2013 document incorporate data released since the earlier publication on essential elements including HF prevention, hypertension management, and treatment of common comorbidities.
The three questions that follow are a quick test of your recall of the most recent update, published in Circulation in April, 2017.
1. You are seeing a patient who has NYHA Class II heart failure and a ferritin level of <100 ng/mL. Based on the recent update to the ACC/AHA/HFSA HF guideline, which of the following is true?
A. Oral iron replacement may be of benefit
B. Oral iron replacement likely has no benefit
C. Intravenous iron replacement may be of benefit
D. Intravenous iron replacement likely has no benefit